ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

MEDITECH Expanse Earns Top Marks in 2023 KLAS Patient Accounting Report

Report examines feedback from health systems with 250 beds or less

MEDITECH Expanse earned the best Overall Performance score in a March 7th report issued by KLAS Research that examines feedback from hospitals 250 beds or less about their patient accounting solutions. The report, titled, “Small-Hospital Patient Accounting,” evaluated six vendors, including the top three in overall EHR market share.

KLAS recognized MEDITECH as the market-share leader in this space, and MEDITECH Expanse as the top-rated solution. Expanse received a score of 87.2 out of a possible 100, nearly four points higher than the next closest vendor. MEDITECH earned the highest score in four out of five of the report’s customer experience pillars, which include culture, operations, product, relationship, and value. The report was composed of 16 numeric ratings questions and four yes/no questions, all rated equally.

MEDITECH’s highest rating was for Value (88.5), scoring 18 points higher than the next closest vendor. The report notes that MEDITECH “drives tangible outcomes by offering a very affordable and stable solution, keeping up with regulatory items, and consistently developing new functionality. All respondents report they are not nickel-and-dimed and receive no unexpected charges. They also say the reporting enables them to understand and meet financial metrics by staying on top of revenue, A/R, and DNFB accounts.”

MEDITECH also earned top marks for Relationship (88), scoring nearly 7 points higher than the second place vendor. The report praised MEDITECH for its partnership and transparency, stating that “executives are available when problems arise, and frontline support staff are helpful, knowledgeable, and effective at resolving concerns quickly and completely.” Respondents also appreciated MEDITECH listening to and implementing their feedback without overpromising.

MEDITECH also earned top scores for Culture and Operations. In the Loyalty pillar, 100% of respondents said MEDITECH Expanse was part of their long term plans and 96% said they would buy again.

Customers surveyed by KLAS expressed their satisfaction with the transparency and automation that Expanse Patient Accounting provides, with one CFO commenting: “The revenue cycle module is excellent. The new system is a step up from the previous system. I can see so much more and get a bigger picture of what is going on with the system now. We have a lot more automation with claims. The entire claims process and collection process is much more efficient with Expanse Patient Accounting” (CFO, September, 2022).

This report comes on the heels of the 2023 Best in KLAS report where MEDITECH earned Best in KLAS for Acute Care EMR (Small). MEDITECH also ranked as one of the top two vendors for Overall Software Suite and Overall Physician Practice Vendor. MEDITECH was a top performer in all segments rated, which also included Acute Care EMR (Midsize 151-400 beds), Home Health EHR (Health System Owned), Ambulatory EMR (Health System Owned), and Practice Management (Health System Owned).

"Patient accounting has been a strength of MEDITECH for as long as we have measured,” said Adam Gale, Co-founder and CEO of KLAS. "Our data, collected from hundreds of healthcare providers, shows that MEDITECH is a leading option for those healthcare organizations in need of a high-quality solution at a reasonable price."

This year, KLAS did not issue Best in KLAS awards for the newly created Patient Accounting & Patient Management small and medium segments due to insufficient survey responses; however MEDITECH previously received the Best in KLAS Patient Accounting & Patient Management (Community) award in 2021 and 2022.

To learn how one MEDITECH customer, Howard County Medical Center, leveraged MEDITECH Expanse Revenue Cycle to reduce self-pay debt by 42%, see our recent success story.

About MEDITECH

MEDITECH empowers healthcare organizations to expand their vision of what’s possible with Expanse, the world’s most intuitive and interoperable EHR. Expanse lays the foundation for the next digital era, enabling care across delivery settings, designing cloud-based systems to drive better outcomes, and providing mobile, personalized solutions to improve efficiency for an overburdened workforce. Visit ehr.meditech.com, find MEDITECH Podcasts on your favorite platform, and follow us on Twitter, Facebook, and LinkedIn.

MEDITECH #Expanse recognized as top-rated solution in 2023 KLAS Patient Accounting report @MEDITECH @KLASresearch

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.